Billable / Specific Code
ICD-10-CM D3A.023 is the diagnosis code for Benign carcinoid tumor of the transverse colon. This code falls under the section "Benign neuroendocrine tumors" within Chapter 2 — Neoplasms (C00-D49). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Always refer to the official ICD-10-CM Tabular List for complete coding guidelines. Ensure documentation supports the specificity of the code selected. When in doubt, consult a certified medical coder or the latest CMS guidelines.
Understanding where D3A.023 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, D3A.023 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
D3A.023 is the ICD-10-CM diagnosis code for "Benign carcinoid tumor of the transverse colon". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of D3A.023 is D3A.02 ("Benign carcinoid tumors of the appendix, large intestine, and rectum"). D3A.023 provides a more specific classification within this category.
D3A.023 is located in Section D3A — "Benign neuroendocrine tumors" within Chapter 2 of the ICD-10-CM Tabular List.
Use D3A.023 when the patients documented diagnosis matches "Benign carcinoid tumor of the transverse colon" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Benign carcinoid tumor of the transverse colon is D3A.023.
Yes, D3A.023 can be used as a primary diagnosis code since it is billable and specific.
D3A.023 is in Chapter 2 of the ICD-10-CM Tabular List.
Yes, D3A.023 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.